Establishment of a clinical grade human iPS cell line
Human induced pluripotent stem cells (hiPSCs) have moved beyond research into application in clinical trials. However, only a limited number of clinical grade hiPSC lines are available. The aim of this project is to generate a clinical grade safe iPSC line under GMP-compliant conditions, including tissue sourcing, manufacturing, testing and storage, as starting point for new internal and externally developed cell therapies.
A Starfish Innovations project